-
A Missed Conversation
Despite national guidelines urging oncologists to bring up risks of infertility posed by cancer treatment, many young cancer patients are never told about these risks or counseled on their fertility preservation options.
by Marcus A. Banks
-
Pushing Progress Forward
NCI Director Norman E. “Ned” Sharpless addresses disparities and maps out plans for the future amid “profound upheaval.”
by Kevin McLaughlin
-
Cancer Care Moves Forward Amid COVID-19
Following the arrival of the coronavirus in the U.S., people with cancer and their doctors are adjusting to new ways of doing things while continuing to seek and provide cancer care.
by Kate Yandell
-
Using Leftover Cancer Drugs to Help Others
Cancer drug repositories that accept unused drugs could provide an affordable source of medications for patients in need, while also providing patients left with extra drugs a way to give back.
by Jon Kelvey
-
Medicare Coverage for Next-Generation Sequencing Tests
Multigene panels that rely on next-generation sequencing are increasingly used to test for hereditary cancer risk-related mutations. The federal government aims to expand Medicare coverage for these tests.
by Ashley P. Taylor
-
Opioid Overdoses in Cancer Patients and Survivors
The number of cancer patients and survivors visiting emergency departments for opioid overdoses more than doubled between 2006 and 2015, but overdoses are still uncommon in this group.
by Emma Yasinski
-
Cancer and Credit
The financial burden of a cancer diagnosis can lower a patient's credit score.
by Shelly Rosenfeld
-
First Ladies of Africa Issue Call to Address Cancer Crisis
A coalition of wives of African leaders, originally dedicated to addressing HIV/AIDS, is now also taking on the growing problem of cancer.
by Bradley D. Miller, PhD
-
Young Colorectal Cancer Patients Are Often Misdiagnosed
A new survey suggests that young adults with colorectal cancer struggle to receive an accurate, prompt diagnosis.
by Bradley Jones
-
Making Clinical Trials More Inclusive
Broadening clinical trial eligibility criteria to include cancer patients who also have other health conditions could increase trial enrollment.
by Ashley P. Taylor
Cancer Talk
Immunotherapy Improves Survival in Bladder Cancer
New research indicates that adding immunotherapy to muscle-invasive bladder cancer treatment can improve event-free and overall survival.
by Laura Gesualdi-Gilmore
Cancer Patients Who Quit Smoking, Even Years After Diagnosis, Live LongerFindings from a recent study support smoking cessation after diagnosis, with the most pronounced effect in those who received treatment within six months of diagnosis.
by Kyle Bagenstose
Delaying Treatment ResistanceAdding a CDK 4/6 inhibitor extends progression-free survival for people with metastatic HR-positive, HER2-positive breast cancer.
by Thomas Celona
2024: The Year in Cancer NewsThe Cancer Today editors share the most impactful reporting on cancer research from 2024.
by Cancer Today staff